Yttrium (90Y) tacatuzumab tetraxetan
(Redirected from Tacatuzumab)
Yttrium (90Y) tacatuzumab tetraxetan is an investigational humanized monoclonal antibody intended for the treatment of cancer.[1] The antibody itself, tacatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90,[2] a radioisotope which destroys the tumour cells.
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "citation/CS1".
- ↑ WHO Drug Information
Script error: No such module "Check for unknown parameters".
Template:Monoclonals for tumors
Template:Asbox
Template:Antineoplastic-drug-stub
Template:Nuclear-med-stub